These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36122581)

  • 1. Childhood growth hormone treatment and metabolic and cardiovascular risk in adults born small for gestational age after growth hormone cessation in the Netherlands: a 12-year follow-up study.
    Goedegebuure WJ; van der Steen M; Smeets CCJ; Hokken-Koelega ACS
    Lancet Child Adolesc Health; 2022 Nov; 6(11):777-787. PubMed ID: 36122581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic health of young adults who were born small for gestational age and treated with growth hormone, after cessation of growth hormone treatment: a 5-year longitudinal study.
    van der Steen M; Smeets CC; Kerkhof GF; Hokken-Koelega AC
    Lancet Diabetes Endocrinol; 2017 Feb; 5(2):106-116. PubMed ID: 28011067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SGA-born adults with postnatal catch-up have a persistently unfavourable metabolic health profile and increased adiposity at age 32 years.
    Goedegebuure WJ; Van der Steen M; Smeets CCJ; Kerkhof GF; Hokken-Koelega ACS
    Eur J Endocrinol; 2022 May; 187(1):15-26. PubMed ID: 35521698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk factors and carotid intima media thickness in young adults born small for gestational age after cessation of growth hormone treatment: a 5-year longitudinal study.
    van der Steen M; Kerkhof GF; Smeets CCJ; Hokken-Koelega ACS
    Lancet Diabetes Endocrinol; 2017 Dec; 5(12):975-985. PubMed ID: 29102566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Study on Metabolic Health in Adults SGA During 5 Years After GH With or Without 2 Years of GnRHa Treatment.
    Goedegebuure WJ; van der Steen M; Kerkhof GF; Hokken-Koelega ACS
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32436961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral white matter hyperintensities in adults born small for gestational age at 12 years after cessation of childhood growth hormone treatment: a prospective cohort study including untreated controls.
    Dorrepaal DJ; Goedegebuure WJ; van der Steen M; Bos D; Hokken-Koelega ACS
    EClinicalMedicine; 2024 Jun; 72():102637. PubMed ID: 38779170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of growth hormone treatment on metabolic and cardiovascular risk factors is similar in preterm and term short, small for gestational age children.
    de Kort SW; Willemsen RH; van der Kaay DC; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):65-73. PubMed ID: 19094073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term impact of GH treatment during childhood on body composition and fat distribution in young adults born SGA.
    Breukhoven PE; Kerkhof GF; van Dijk M; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3710-6. PubMed ID: 21917862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fat distribution in short-stature children born small for gestational age.
    Maeyama T; Ida S; Onuma S; Shoji Y; Yamamoto T; Etani Y; Kawai M
    Pediatr Int; 2020 Dec; 62(12):1351-1356. PubMed ID: 32521070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrovascular Abnormalities in Adults Born SGA at 12 Years After Growth Hormone Cessation Compared to Controls.
    Dorrepaal DJ; Goedegebuure WJ; Smagge L; van der Steen M; van der Lugt A; Hokken-Koelega ACS
    J Clin Endocrinol Metab; 2024 Feb; 109(3):e1185-e1193. PubMed ID: 37855389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular filtration rate, blood pressure and microalbuminuria in adults born SGA: A 5-year longitudinal study after cessation of GH treatment.
    Goedegebuure WJ; Kerkhof GF; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):892-898. PubMed ID: 31512772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small for gestational age (SGA): endocrine and metabolic consequences and effects of growth hormone treatment.
    Hokken-Koelega AC; De Waal WJ; Sas TC; Van Pareren Y; Arends NJ
    J Pediatr Endocrinol Metab; 2004 Mar; 17 Suppl 3():463-9. PubMed ID: 15134308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum insulin-like growth factor-binding protein-2 levels and metabolic and cardiovascular risk factors in young adults and children born small for gestational age.
    de Kort SW; van Doorn J; van de Sande AG; Leunissen RW; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2010 Feb; 95(2):864-71. PubMed ID: 20061427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (sga) and untreated short SGA controls.
    van Dijk M; Bannink EM; van Pareren YK; Mulder PG; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Jan; 92(1):160-5. PubMed ID: 17062774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
    Sas T; Mulder P; Hokken-Koelega A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auxological and metabolic effects of long-term treatment with recombinant growth hormone in children born small for gestational age: a retrospective study.
    Ferrigno R; Savanelli MC; Cioffi D; Pellino V; Klain A
    Endocrine; 2024 Apr; 84(1):213-222. PubMed ID: 38214878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age (SGA).
    Arends NJ; Boonstra VH; Duivenvoorden HJ; Hofman PL; Cutfield WS; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):44-50. PubMed ID: 15638869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of size at birth, childhood growth patterns and growth hormone treatment on leukocyte telomere length.
    Smeets CC; Codd V; Denniff M; Samani NJ; Hokken-Koelega AC
    PLoS One; 2017; 12(2):e0171825. PubMed ID: 28178350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Health and Long-Term Safety of Growth Hormone Treatment in Silver-Russell Syndrome.
    Smeets CC; Renes JS; van der Steen M; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2017 Mar; 102(3):983-991. PubMed ID: 28001454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.